D-0859-2020 Class III Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-0859-2020 was initiated by Akorn, Inc. on Feb 21, 2020 and is designated Class III. Reason for recall: Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube. The recall status is terminated (terminated Jul 28, 2022). Affected quantity: 720 tubes.

Recall details

Product Type
Drugs
Report Date
Mar 4, 2020
Initiation Date
Feb 21, 2020
Termination Date
Jul 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
720 tubes

Product description

Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-622-35

Reason for recall

Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.

Distribution pattern

Nationwide within United States and Puerto Rico

Code information

Lot #: 8B66A, Exp. Date 01/2021; Lot 8C91A, Exp. Date 02/2021; Lots 8F07A, 8F16A, Exp. Date 05/2021; Lot 8F13A, Exp. Date 07/2021.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0859-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0859-2020. Report a data issue: hello@regdatalab.com.